We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+14.52%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
–
AUM
$128M
AUM Growth
+$13.5M
Cap. Flow
-$1.11M
Cap. Flow %
-0.87%
Top 10 Hldgs %
26.71%
Holding
1,141
New
64
Increased
222
Reduced
212
Closed
55

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$189K
2
EQIX icon
Equinix
EQIX
+$93.7K
3
ALGN icon
Align Technology
ALGN
+$77.8K
4
MU icon
Micron Technology
MU
+$65.9K
5
AVGO icon
Broadcom
AVGO
+$63.2K

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$949K
2
DLR.PRH.CL
Digital Realty Trust, Inc.
DLR.PRH.CL
+$296K
3
JNJ icon
Johnson & Johnson
JNJ
+$274K
4
ACWX icon
iShares MSCI ACWI ex US ETF
ACWX
+$144K
5
TSM icon
TSMC
TSM
+$95.4K

Sector Composition

Rank Sector Weight
1 Technology 28.37%
2 Healthcare 12.61%
3 Financials 10.22%
4 Consumer Staples 7.19%
5 Consumer Discretionary 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EFV icon
551
iShares MSCI EAFE Value ETF
EFV
$27.6B
$5K ﹤0.01%
110
– –
GDDY icon
552
GoDaddy
GDDY
$12.3B
$5K ﹤0.01%
62
– –
GWW icon
553
W.W. Grainger
GWW
$65.3B
$5K ﹤0.01%
15
-18
-55% -$5.35K
HAE icon
554
Haemonetics
HAE
$3.58B
$5K ﹤0.01%
61
– –
IART icon
555
Integra LifeSciences
IART
$1.54B
$5K ﹤0.01%
84
– –
IWM icon
556
iShares Russell 2000 ETF
IWM
$80.9B
$5K ﹤0.01%
35
– –
IX icon
557
ORIX
IX
$44B
$5K ﹤0.01%
325
-100
-24% -$1.48K
J icon
558
Jacobs Solutions
J
$15.9B
$5K ﹤0.01%
85
– –
JAZZ icon
559
Jazz Pharmaceuticals
JAZZ
$15.9B
$5K ﹤0.01%
32
+14
+78% +$1.83K
KSS icon
560
Kohl's
KSS
$2.03B
$5K ﹤0.01%
68
+22
+48% +$1.49K
KWR icon
561
Quaker Houghton
KWR
$2.63B
$5K ﹤0.01%
25
– –
LII icon
562
Lennox International
LII
$18.8B
$5K ﹤0.01%
19
– –
M icon
563
Macy's
M
$6.15B
$5K ﹤0.01%
200
+104
+108% +$2.63K
MJ icon
564
Amplify Alternative Harvest ETF
MJ
$101M
$5K ﹤0.01%
+13
New +$5.36K
NEE icon
565
NextEra Energy
NEE
$187B
$5K ﹤0.01%
112
– –
NTR icon
566
Nutrien
NTR
$32.7B
$5K ﹤0.01%
97
+68
+234% +$3.54K
NVO
567
Novo Nordisk
NVO
$216B
$5K ﹤0.01%
176
-192
-52% -$4.72K
PCG icon
568
PG&E
PCG
$47.8B
$5K ﹤0.01%
300
– –
PINC
569
DELISTED
Premier
PINC
$5K ﹤0.01%
133
– –
RBC icon
570
RBC Bearings
RBC
$18.8B
$5K ﹤0.01%
39
– –
RWO icon
571
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.32B
$5K ﹤0.01%
103
– –
SAM icon
572
Boston Beer
SAM
$1.88B
$5K ﹤0.01%
17
– –
SBGI icon
573
Sinclair Inc
SBGI
$974M
$5K ﹤0.01%
122
– –
SHY icon
574
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$5K ﹤0.01%
60
– –
SUI icon
575
Sun Communities
SUI
$15B
$5K ﹤0.01%
39
– –
21 22
23
24 25

Similar funds

SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return
RHP
Royal Harbor Partners Houston, Texas $295M AUM 14.06% 1-Year Est. Return
MSWM
Master's Wealth Management Lancaster, Pennsylvania $295M AUM 15.96% 1-Year Est. Return
RLIM
Red Lighthouse Investment Management New York $296M AUM 22.04% 1-Year Est. Return
JCM
Jacobsen Capital Management Salt Lake City, Utah $296M AUM 24.47% 1-Year Est. Return
CA
Claar Advisors New York $295M AUM 12.26% 1-Year Est. Return
NRC
New Republic Capital Charlotte, North Carolina $297M AUM 24.5% 1-Year Est. Return
MFC
Morris Financial Concepts Mount Pleasant, South Carolina $295M AUM 17.25% 1-Year Est. Return

Front Row Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Front Row Advisors held 1,141 positions worth $128M, up 12% from $115M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Front Row Advisors's Q1 2019 filing shows 64 new, 222 increased, 212 reduced and 55 closed positions. Its largest new stake was Vanguard Value ETF: 539 shares worth $58K. The largest sale was Biogen, an estimated $949K.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Front Row Advisors's largest Q1 2019 buy was Vanguard Value ETF: 539 shares worth $58K.
  • Front Row Advisors added most to NVIDIA in Q1 2019, an estimated $189K increase.
  • Front Row Advisors's biggest Q1 2019 reduction was Biogen, cutting an estimated $949K.
  • Front Row Advisors fully exited Digital Realty Trust, Inc. in Q1 2019, selling an estimated $296K.
  • Front Row Advisors's ten largest holdings make up 27% of its $128M portfolio in Q1 2019.
  • Front Row Advisors opened 64 new positions and closed 55 in Q1 2019.
  • Front Row Advisors's portfolio value rose 12% quarter-over-quarter to $128M.

Based on Front Row Advisors's 13F filing for Q1 2019, filed 16 May 2019.